GeoVax Labs, Inc. Net Income Loss

• GeoVax Labs, Inc. showed an increase of +3.8% in Net Income Loss from 2023 to 2024.
• This data is from GeoVax Labs, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
• XBRL data for this metric is available from 2005 to 2024 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 20 years of available data (2005 to 2024), GeoVax Labs, Inc.'s Net Income Loss has declined by 1,451.3%.
• Historical annual values: Fiscal year 2024: -$24.99 million | Fiscal year 2023: -$25.97 million | Fiscal year 2022: -$14.02 million | Fiscal year 2021: -$18.57 million | Fiscal year 2020: -$2.96 million | Fiscal year 2019: -$2.37 million | Fiscal year 2018: -$2.56 million | Fiscal year 2017: -$2.17 million | Fiscal year 2016: -$3.27 million | Fiscal year 2015: -$2.69 million | Fiscal year 2014: -$2.73 million | Fiscal year 2013: -$2.28 million | Fiscal year 2012: -$2.14 million | Fiscal year 2011: -$2.35 million | Fiscal year 2010: -$2.75 million | Fiscal year 2009: -$3.28 million | Fiscal year 2008: -$3.73 million | Fiscal year 2007: -$4.24 million | Fiscal year 2006: -$584.2 thousand | Fiscal year 2005: -$1.61 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026